Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas
Mathias J Rummel
The role of patients and patient groups in the European Reference Network EuroBloodNet
Joan Lluis Vives-Corrons et al.
What is the best treatment in the next few years to achieve more treatment-free remission in CML?
The potential impact of biosimilars in hematology